Prof. Dr. Frank Dörje



Organisation


Professur für Molekulare und Klinische Pharmazie
Lehrstuhl für Pharmazeutische Technologie
Naturwissenschaftliche Fakultät


Publications (Download BibTeX)


Duerr, P., Schlichtig, K., Dörje, F., & Fromm, M. (2019). Medication safety in patients treated with new oral antitumor agents: a prospective, randomized investigation on the impact of intensified clinical pharmaceutical/ clinical pharmacological care on patient safety and well-being (AMBORA-Study - supported by the German Cancer Aid (70112447)). In NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Stuttgart, GERMANY: NEW YORK: SPRINGER.
Schlichtig, K., Duerr, P., Dörje, F., & Fromm, F. (2019). Medication safety of new oral antitumor agents: a randomized trial on the impact of a clinical pharmacological / pharmaceutical intervention on drug-related problems and patient safety. In EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (pp. S18-S18). Stockholm, SE: HEIDELBERG: SPRINGER HEIDELBERG.
Grafe, C., Semrau, S., Hein, A., Beckmann, M., Mackensen, A., Dörje, F., & Fromm, M. (2018). Dose adjustment of cisplatin, etoposide, and ifosfamide according to kidney function: a retrospective analysis and implications for medication safety. Naunyn-Schmiedeberg's Archives of Pharmacology, 391(2), 219-229. https://dx.doi.org/10.1007/s00210-017-1456-2
Dircks, M., Mayr, A., Freidank, A., Kornhuber, J., Dörje, F., & Friedland, K. (2017). Advances in clinical pharmacy education in Germany: a quasi-experimental single-blinded study to evaluate a patient-centred clinical pharmacy course in psychiatry. Bmc Medical Education, 17(1). https://dx.doi.org/10.1186/s12909-017-1092-z
Zaloga, J., Poettler, M., Leitinger, G., Friedrich, R.P., Almer, G., Lyer, S.,... Alexiou, C. (2016). Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting. European Journal of Pharmaceutics and Biopharmaceutics, 101, 152-62. https://dx.doi.org/10.1016/j.ejpb.2016.01.017
Wein, A., Emmert, M., Merkel, S., Harich, H.-D., Siebler, J., Thiemann, R.,... Hohenberger, W. (2015). Palliative Treatment of Colorectal Cancer with Secondary Metastasis Resection in Germany - Impact of the Multidisciplinary Treatment Approach on Prognosis and Cost: The Northern Bavaria IVOPAK I Project. Oncology, 88(2), 103 - 121. https://dx.doi.org/10.1159/000368246
Joost, R., Dörje, F., Schwitulla, J., Eckardt, K.-U., & Hugo, C. (2014). Intensified pharmaceutical care is improving immunosuppressive medication adherence in kidney transplant recipients during the first post-transplant year: a quasi-experimental study. Nephrology Dialysis Transplantation, 29(8), 1597-607. https://dx.doi.org/10.1093/ndt/gfu207
Atreya, R., Neumann, H., Neufert, C., Waldner, M., Billmeier, U., Zopf, Y.,... Neurath, M. (2014). In vivo imaging using fluorescent antibodies to tumor necrosis factor predicts therapeutic response in Crohn's disease. Nature Medicine, 20(3), 313-8. https://dx.doi.org/10.1038/nm.3462
Emmert, M., Pohl-Dernick, K., Wein, A., Dörje, F., Merkel, S., Boxberger, F.,... Schöffski, O. (2012). Palliative treatment of colorectal cancer in Germany: cost of care and quality of life. European Journal of Health Economics, 14(4), 629 - 638. https://dx.doi.org/10.1007/s10198-012-0408-5

Last updated on 2016-11-06 at 05:11